Breaking News

Evonik Launches Plant-based Squalene to Boost Vax Efficacy

PhytoSquene is an alternative to animal-derived squalene, which for pharmaceutical applications is typically sourced from shark liver oil.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene. Non-GMP samples of PhytoSquene are available immediately with GMP quality to follow in 2023.   PhytoSquene is an alternative to animal-derived squalene, which for pharmaceutical ap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters